UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form FORM 10-Q
| (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended September 30, 2021March 31, 2022
or
☐ TRANSITION REPORT UNDER SECTION 13 OR
|
|
For the transition period from ________ to ___________To
Commission file number: File Number 333-130606000-55909
NAMLIONG SKYCOSMOS, INC.
(Exact name of registrant as specified in its charter)
| 20-3240178 | |
( incorporation or organization) | (IRS Employer Identification No.) |
Yongkang District Tainan City, Taiwan |
| |
|
| |
| ||
|
| |
(Address of | (Zip Code) |
(801) 209-0740
(Issuer’s Telephone Number)
(Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report)
+886-2542372 |
(Registrant’s telephone number, including area code) |
Kreido Biofuels, Inc. |
(Former name, former address and former fiscal year, if changed since last report) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
|
|
| N/A |
Securities registered pursuant to Section 12(g) of the Act:
N/A(Title of class)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the pastpreceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No YES☐ NO
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No YES☐ NO
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitionthe definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company”company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer | ☐ | Accelerated | ☐ |
|
|
|
| Smaller reporting company | ☒ | ||
Emerging | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No YES☐ NO
APPLICABLE ONLY TO CORPORATE ISSUERS
State theThe number of shares outstanding of each of the issuer’s classes of common equity, as of the latest practicable date. As of November 12, 2021, the Company had outstanding 2,706,513 shares ofregistrant’s common stock, par value $0.001$0.0001 per share.share, as of May 10, 2022, was .
TABLE OF CONTENTS
Page | ||
PART I - FINANCIAL INFORMATION |
Item 1. Financial Statements | 1 | |
PART I
FINANCIAL INFORMATION
The Condensed Consolidated Financial Statements of the Company are prepared as of September 30, 2021.
ITEM 1. FINANCIAL STATEMENTS REQUIRED BY FORM 10-Q
CONTENTS
| 1 | ||
| 2 | ||
| |||
| 3 | ||
|
|
Kreido Biofuels, Inc. | ||||||||
Condensed Balance Sheets | ||||||||
(Unaudited) | ||||||||
|
|
|
|
|
|
| ||
ASSETS | ||||||||
|
|
|
|
|
|
| ||
|
| September 30, |
|
| December 31, |
| ||
|
| 2021 |
|
| 2020 |
| ||
|
|
|
|
|
|
| ||
CURRENT ASSETS |
|
|
|
|
|
| ||
|
|
|
|
|
|
| ||
Cash |
| $ | 37,693 |
|
| $ | 0 |
|
Prepaid Expenses |
|
| 0 |
|
|
| 0 |
|
|
|
|
|
|
|
|
|
|
Total Current Assets |
|
| 37,693 |
|
|
| 0 |
|
|
|
|
|
|
|
|
|
|
TOTAL ASSETS |
|
| 37,693 |
|
|
| 0 |
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS’ DEFICIT | ||||||||
|
|
|
|
|
|
|
|
|
CURRENT LIABILITIES |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts Payable |
|
| 36,478 |
|
|
| 35,817 |
|
Promissory note |
|
| 51,000 |
|
|
| 0 |
|
Related Party Payable |
|
| 34,596 |
|
|
| 33,621 |
|
|
|
|
|
|
|
|
|
|
Total Current Liabilities |
|
| 122,074 |
|
|
| 69,438 |
|
|
|
|
|
|
|
|
|
|
LONG TERM LIABILITIES |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Long Term Liabilities |
|
| 0 |
|
|
| 0 |
|
|
|
|
|
|
|
|
|
|
Total Liabilities |
| $ | 122,074 |
|
| $ | 69,438 |
|
|
|
|
|
|
|
|
|
|
STOCKHOLDERS’ DEFICIT |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock; 10,000,000 shares authorized, at $0.001 par value, 0 shares issued and outstanding |
|
| 0 |
|
|
| 0 |
|
Common stock; 300,000,000 shares authorized, at $0.001 par value, 2,706,513 and 1,956,513 shares issued and outstanding, respectively |
|
| 1,956 |
|
|
| 1,956 |
|
Common stock to be issued |
|
| 750 |
|
|
| 0 |
|
Additional paid-in capital |
|
| 49,396,627 |
|
|
| 48,984,877 |
|
Accumulated Deficit |
|
| (49,483,714 | ) |
|
| (49,056,271 | ) |
|
|
|
|
|
|
|
|
|
Total Stockholders’ Deficit |
|
| (84,381 | ) |
|
| (69,438 | ) |
|
|
|
|
|
|
|
|
|
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT |
| $ | 37,693 |
|
| $ | 0 |
|
i |
CAUTIONARY NOTE CONCERNING FORWARD-LOOKING STATEMENTS
This Quarterly Report on Form 10-Q includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended that are not historical facts, and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical facts, included in this Form 10-Q including, without limitation, statements in the “Market Overview” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the Company’s market projections, financial position, business strategy and the plans and objectives of management for future operations, events or developments which the Company expects or anticipates will or may occur in the future, including such things as future capital expenditures (including the amount and nature thereof); expansion and growth of the Company's business and operations; and other such matters are forward-looking statements. These statements are based on certain assumptions and analyses made by the Company in light of its experience and its perception of historical trends, current conditions and expected future developments, as well as other factors it believes are appropriate under the circumstances. However, whether actual results or developments will conform with the Company's expectations and predictions is subject to a number of risks and uncertainties, including general economic, market and business conditions; the business opportunities (or lack thereof) that may be presented to and pursued by the Company; changes in laws or regulation; and other factors, most of which are beyond the control of the Company.
These forward-looking statements can be identified by the use of predictive, future-tense or forward-looking terminology, such as “believes,” “anticipates,” “expects,” “estimates,” “plans,” “may,” “will,” or similar terms. These statements appear in a number of places in this filing and include statements regarding the intent, belief or current expectations of the Company, and its directors or its officers with respect to, among other things: (i) trends affecting the Company's financial condition or results of operations for its limited history; (ii) the Company's business and growth strategies; and (iii) the Company's financing plans. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve significant risks and uncertainties, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors. Such factors that could adversely affect actual results and performance include, but are not limited to, the Company's limited operating history, potential fluctuations in quarterly operating results and expenses, government regulation, technological change and competition.
Consequently, all of the forward-looking statements made in this Form 10-Q are qualified by these cautionary statements and there can be no assurance that the actual results or developments anticipated by the Company will be realized or, even if substantially realized, that they will have the expected consequence to or effects on the Company or its business or operations. The Company assumes no obligations to update any such forward-looking statements.
ii |
PART I. FINANCIAL INFORMATION.
Item 1. Financial Statements
NAMLIONG SKYCOSMOS, INC.
(Formerly Kreido Biofuels, Inc.)
CONDENSED BALANCE SHEETS
(Currency expressed in United States Dollars (“US$”), except for number of shares)
March 31, 2022 | December 31, 2021 | |||||||
(Unaudited) | (Audited) | |||||||
ASSETS | ||||||||
Current asset: | ||||||||
Cash | $ | 0 | $ | 0 | ||||
TOTAL ASSETS | $ | – | $ | – | ||||
LIABILITIES AND STOCKHOLDERS’ DEFICIT | ||||||||
Current liabilities: | ||||||||
Accounts payable and accrued liabilities | $ | 7,000 | $ | 755 | ||||
Amount due to a related party | 28,505 | 0 | ||||||
Total current liabilities | 35,505 | 755 | ||||||
TOTAL LIABILITIES | 35,505 | 755 | ||||||
Commitments and contingencies | – | – | ||||||
STOCKHOLDERS’ DEFICIT | ||||||||
Preferred stock, | shares authorized, $ par value, shares issued and outstanding as of March 31, 2022 and December 31, 20210 | 0 | ||||||
Common stock, | shares authorized, $ par value, and shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively14,706 | 14,706 | ||||||
Additional paid-in capital | 49,435,627 | 49,435,627 | ||||||
Accumulated deficit | (49,485,838 | ) | (49,451,088 | ) | ||||
Stockholders’ deficit | (35,505 | ) | (755 | ) | ||||
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT | $ | 0 | $ | 0 |
See accompanying notes are an integral part of these unauditedto condensed financial statements.
Kreido Biofuels, Inc. | ||||||||||||||||
Condensed Statements of Operations | ||||||||||||||||
(Unaudited) | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
|
| For the Three Months Ended |
|
| For the Nine Months Ended |
| ||||||||||
|
| September 30, |
|
| September 30, |
| ||||||||||
|
| 2021 |
|
| 2020 |
|
| 2021 |
|
| 2020 |
| ||||
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
REVENUES |
| $ | 0 |
|
| $ | 0 |
|
| $ | 0 |
|
| $ | 0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EXPENSES |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Professional Fees |
|
| 11,273 |
|
|
| 2,500 |
|
|
| (11,273 | ) |
|
| 5,000 |
|
General and administrative |
|
| 414,133 |
|
|
| 872 |
|
|
| (416,170 | ) |
|
| 5,307 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Expenses |
|
| 425,406 |
|
|
| 3,372 |
|
|
| (427,443 | ) |
|
| 10,307 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LOSS FROM OPERATIONS |
|
| (425,406 | ) |
|
| (3,372 | ) |
|
| (427,443 | ) |
|
| (10,307 | ) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NET LOSS |
| $ | (425,406 | ) |
| $ | (5,264 | ) |
| $ | (427,443 | ) |
| $ | (10,307 | ) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BASIC AND DILUTED LOSS PER SHARE |
| $ | (0.22 | ) |
| $ | (0.00 | ) |
| $ | (0.21 | ) |
| $ | (0.00 | ) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BASIC AND DILUTED WEIGHTED AVERAGE |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NUMBER OF COMMON SHARES |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OUTSTANDING |
|
| 1,956,513 |
|
|
| 1,956,452 |
|
|
| 1,956,513 |
|
|
| 1,956,452 |
|
TheNAMLIONG SKYCOSMOS, INC.
(Formerly Kreido Biofuels, Inc.)
CONDENSED STATEMENTS OF OPERATIONS
(Currency expressed in United States Dollars (“US$”), except for number of shares)
(Unaudited)
Three months ended March 31, | ||||||||
2022 | 2021 | |||||||
Revenue, net | $ | 0 | $ | 0 | ||||
Operating expenses: | ||||||||
General and administrative expenses | 34,750 | 2,300 | ||||||
Total operating expenses | 34,750 | 2,300 | ||||||
LOSS FROM OPERATION | (34,750 | ) | (2,300 | ) | ||||
Income tax expense | 0 | 0 | ||||||
NET LOSS | $ | (34,750 | ) | $ | (2,300 | ) | ||
Net loss per share – Basic and Diluted | ||||||||
Basic | $ | (0.00 | ) | $ | (0.00 | ) | ||
Diluted | $ | (0.00 | ) | $ | (0.00 | ) | ||
Weighted average common shares outstanding | ||||||||
Basic | 14,706,513 | 1,956,452 | ||||||
Diluted | 14,706,513 | 1,956,452 |
See accompanying notes are an integral part of these unaudited financial statements
Kreido Biofuels, INC. | ||||||||||||||||||||||||
Condensed Statements of Stockholders’ Deficit | ||||||||||||||||||||||||
(Unaudited) | ||||||||||||||||||||||||
| ||||||||||||||||||||||||
|
| Nine-Month Period Ended September 30, 2020 |
| |||||||||||||||||||||
|
|
|
|
|
|
|
| Common |
|
|
|
|
|
|
|
|
|
| ||||||
|
| Common Stock |
|
| stock |
|
| Additional |
|
| Accumulated |
|
|
|
| |||||||||
|
| Shares | Amount |
|
| to be issued |
|
| Paid-In |
|
| Deficit |
|
| Total |
| ||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, December 31, 2019 |
|
| 1,956,452 |
|
| $ | 1,956 |
|
|
| 0 |
|
| $ | 48,984,877 |
|
| $ | (49,044,627 | ) |
| $ | (57,794 | ) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
| - |
|
|
| 0 |
|
|
| 0 |
|
|
| 0 |
|
|
| (10,307 | ) |
|
| (10,307 | ) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, September 30, 2020 |
|
| 1,956,452 |
|
| $ | 1,956 |
|
|
| 0 |
|
| $ | 48,984,877 |
|
| $ | (46,054,934 | ) |
|
| (68,101 | ) |
|
| Nine-Month Period Ended September 30, 2021 |
| |||||||||||||||||||||
|
|
|
|
|
|
|
| Common |
|
| Additional |
|
|
|
|
|
|
| ||||||
|
| Common Stock |
|
| stock |
|
| Paid-In |
|
| Accumulated |
|
|
|
| |||||||||
|
| Shares |
|
| Amount |
|
| to be issued |
|
| Capital |
|
| Deficit |
|
| Total |
| ||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||
Balance, December 31, 2020 |
|
| 1,956,452 |
|
| $ | 1,956 |
|
| $ | 0 |
|
| $ | 48,984,877 |
|
| $ | (49,056,271 | ) |
| $ | (69,438 | ) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fractional shares from reverse split |
|
| 61 |
|
|
| - |
|
|
| - |
|
|
| - |
|
|
| - |
|
|
| - |
|
Shares issued for services |
|
| - |
|
|
| 0 |
|
|
| 750 |
|
|
| 411,750 |
|
|
| 0 |
|
|
| 412,500 |
|
Net loss |
|
| - |
|
|
| 0 |
|
|
|
|
|
|
| 0 |
|
|
| (427,443 | ) |
|
| (427,443 | ) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, September 30, 2021 |
|
| 1,956,513 |
|
| $ | 1,956 |
|
| $ | 750 |
|
| $ | 49,396,627 |
|
| $ | (49,483,714 | ) |
|
| (84,381 | ) |
The accompanying notes are an integral part of theseto condensed consolidated financial statements.
Kreido Biofuels, INC. | ||||||||||||||||||||||||
Condensed Statements of Stockholders’ Deficit | ||||||||||||||||||||||||
(Unaudited) | ||||||||||||||||||||||||
| ||||||||||||||||||||||||
|
| Three-Month Period Ended September 30, 2020 |
| |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||||||||
|
|
|
|
|
| Common |
|
| Additional |
|
|
|
|
| ||||||||||
|
| Common Stock |
|
| stock |
|
| Paid-In |
|
| Accumulated |
|
|
| ||||||||||
|
| Shares |
|
| Amount |
|
| to be issued |
|
| Capital |
|
| Deficit |
|
| Total |
| ||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||
Balance, December 31, 2019 |
|
| 1,956,452 |
|
| $ | 1,956 |
|
| $ | - |
|
| $ | 48,984,877 |
|
| $ | (49,044,627 | ) |
| $ | (57,794 | ) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (1,671 | ) |
|
| (1,671 | ) |
Balance, March 31, 2020 |
|
| 1,956,452 |
|
| $ | 1,956 |
|
| $ | 0 |
|
| $ | 48,984,877 |
|
| $ | (49,046,298 | ) |
| $ | (59,465 | ) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (5,264 | ) |
|
| (5,264 | ) |
Balance, June 30, 2020 |
|
| 1,956,452 |
|
| $ | 1,956 |
|
| $ | 0 |
|
| $ | 48,984,877 |
|
| $ | (49,051,562 | ) |
|
| (64,729 | ) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
| - |
|
|
| 0 |
|
|
|
|
|
|
| 0 |
|
|
| (3,372 | ) |
|
| (3,372 | ) |
Balance, September 30, 2020 |
|
| 1,956,452 |
|
| $ | 1,956 |
|
| $ | 0 |
|
| $ | 48,984,877 |
|
| $ | (49,054,934 | ) |
| $ | (68,101 | ) |
|
| Three-Month Period Ended September 30, 2021 |
| |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||
|
|
|
|
|
|
|
| Common |
|
| Additional |
|
|
|
|
|
|
| ||||||
|
| Common Stock |
|
| stock |
|
| Paid-In |
|
| Accumulated |
|
|
|
| |||||||||
|
| Shares |
|
| Amount |
|
| to be issued |
|
| Capital |
|
| Deficit |
|
| Total |
| ||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||
Balance, December 31, 2020 |
|
| 1,956,452 |
|
| $ | 1,956 |
|
| $ | - |
|
| $ | 48,984,877 |
|
| $ | (49,056,271 | ) |
| $ | (69,438 | ) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
| - |
|
|
| 0 |
|
|
| 0 |
|
|
| 0 |
|
|
| (2,300 | ) |
|
| (2,300 | ) |
Balance, March 31, 2021 |
|
| 1,956,452 |
|
| $ | 1,956 |
|
| $ | 0 |
|
| $ | 48,984,877 |
|
| $ | (49,058,571 | ) |
| $ | (71,738 | ) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
| - |
|
|
| 0 |
|
|
| 0 |
|
|
| 0 |
|
|
| 263 |
|
|
| 263 |
|
Balance, June 30, 2021 |
|
| 1,956,452 |
|
| $ | 1,956 |
|
| $ | 0 |
|
| $ | 48,984,877 |
|
| $ | (49,058,308 | ) |
|
| (71,475 | ) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fractional shares from reverse split |
|
| 61 |
|
|
| 0 |
|
|
| 0 |
|
|
| 0 |
|
|
| 0 |
|
|
| 0 |
|
Shares issued for services |
|
| - |
|
|
| 0 |
|
|
| 750 |
|
|
| 411,750 |
|
|
| 0 |
|
|
| 412,500 |
|
Net loss |
|
| - |
|
|
| 0 |
|
|
| 0 |
|
|
| 0 |
|
|
| (425,406 | ) |
|
| (425,406 | ) |
Balance, September 30, 2021 |
|
| 1,956,513 |
|
| $ | 1,956 |
|
| $ | 750 |
|
| $ | 49,396,627 |
|
| $ | (49,483,714 | ) |
| $ | (84,381 | ) |
The
NAMLIONG SKYCOSMOS, INC.
(Formerly Kreido Biofuels, Inc.)
CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT
(Currency expressed in United States Dollars (“US$”), except for number of shares)
(Unaudited)
Three Months Ended March 31, 2022 and 2021 | ||||||||||||||||||||
Common stock | Additional paid-in | Accumulated | Total stockholders’ | |||||||||||||||||
No. of shares | Amount | capital | deficit | deficit | ||||||||||||||||
Balance as of January 1, 2021 | 1,956,452 | $ | 1,956 | $ | 48,984,877 | $ | (49,057,571 | ) | $ | (69,438 | ) | |||||||||
Net loss for the period | – | – | – | (2,300 | ) | (2,300 | ) | |||||||||||||
Balance as of March 31, 2021 | 1,956,452 | $ | 1,956 | $ | 48,984,877 | $ | (49,059,871 | ) | $ | (71,738 | ) | |||||||||
Balance as of January 1, 2022 | 14,706,513 | $ | 14,706 | $ | 49,435,627 | $ | (49,451,088 | ) | $ | (755 | ) | |||||||||
Net loss for the period | – | – | – | (34,750 | ) | (34,750 | ) | |||||||||||||
Balance as of March 31, 2022 | 14,706,513 | $ | 14,706 | $ | 49,435,627 | $ | (49,485,838 | ) | $ | (35,505 | ) |
See accompanying notes are an integral part of theseto condensed consolidated financial statements.
Kreido Biofuels, Inc. | |||||||||
Condensed Statements of Cash Flows | |||||||||
(Unaudited) | |||||||||
|
|
|
|
|
|
| |||
|
| For the Nine Months Ended |
| ||||||
|
| September 30, |
| ||||||
|
| 2021 |
|
| 2020 |
| |||
|
|
|
|
|
|
| |||
CASH FLOWS FROM |
|
|
|
|
|
| |||
OPERATING ACTIVITIES |
|
|
|
|
|
| |||
|
|
|
|
|
|
| |||
Net loss |
| $ | (427,443 | ) |
| $ | (10,307 | ) | |
Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
|
|
|
|
|
| |
Stock based compensation expense |
|
| 412,500 |
|
|
|
|
| |
Changes in operating assets and liabilities: |
|
|
|
|
|
|
|
| |
Change in account payable - related party |
|
| 661 |
|
|
| 1,109 |
| |
Change in accounts payable |
|
| 975 |
|
|
| 9,198 |
| |
|
|
|
|
|
|
|
|
| |
Net Cash Used in |
|
|
|
|
|
|
|
| |
Operating Activities |
|
| (13,307 | ) |
|
| 0 |
| |
|
|
|
|
|
|
|
|
| |
CASH FLOWS FROM INVESTING ACTIVITIES |
|
| 0 |
|
|
| 0 |
| |
|
|
|
|
|
|
|
|
| |
CASH FLOWS FROM FINANCING ACTIVITIES |
|
| - |
|
|
| - |
| |
|
|
|
|
|
|
|
|
| |
Proceeds from promissory note |
|
| 51,000 |
|
|
| 0 |
| |
|
|
|
|
|
|
|
|
| |
Net Cash Provided by |
|
|
|
|
|
|
|
| |
Financing Activities |
|
| 51,000 |
|
|
| 0 |
| |
|
|
|
|
|
|
|
|
| |
NET INCREASE IN CASH |
|
| 37,693 |
|
|
| 0 |
| |
|
|
|
|
|
|
|
|
| |
CASH AT BEGINNING OF PERIOD |
|
| 0 |
|
|
| - |
| |
|
|
|
|
|
|
|
|
| |
CASH AT END OF PERIOD |
| $ | 37,693 |
|
| $ | 0 |
| |
|
|
|
|
|
|
|
|
| |
SUPPLEMENTAL DISCLOSURES OF |
|
|
|
|
|
|
|
| |
CASH FLOW INFORMATION |
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
| |
CASH PAID FOR: |
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
| |
Interest |
| $ | 0 |
|
| $ | 0 |
| |
Income Taxes |
| $ | 0 |
|
| $ | 0 |
| |
|
|
|
|
|
|
|
|
| |
NON-CASH INVESTING AND FINANCING ACTIVITIES |
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
| |
Stock issued for debt |
| $ | 0 |
|
| $ | 0 |
|
The
NAMLIONG SKYCOSMOS, INC.
(Formerly Kreido Biofuels, Inc.)
CONDENSED STATEMENTS OF CASH FLOWS
(Currency expressed in United States Dollars (“US$”))
(Unaudited)
Three months ended March 31, | ||||||||
2022 | 2021 | |||||||
Cash flows from operating activities: | ||||||||
Net loss | $ | (34,750 | ) | $ | (2,300 | ) | ||
Change in operating assets and liabilities: | ||||||||
Accounts payable and accrued liabilities | 6,245 | 975 | ||||||
Accounts payable, related party | 0 | 1,325 | ||||||
Net cash used in operating activities | (28,505 | ) | 0 | |||||
Cash flows from financing activities: | ||||||||
Advance from a related party | 28,505 | 0 | ||||||
Net cash provided by financing activities | 28,505 | 0 | ||||||
Net change in cash and cash equivalents | – | – | ||||||
BEGINNING OF PERIOD | 0 | 0 | ||||||
END OF PERIOD | $ | 0 | $ | 0 | ||||
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: | ||||||||
Cash paid for income taxes | $ | 0 | $ | 0 | ||||
Cash paid for interest | $ | 0 | $ | 0 |
See accompanying notes are an integral part of these unauditedto condensed financial statements.
KREIDO BIOFUELS,NAMLIONG SKYCOSMOS, INC.
Notes to Condensed Financial Statements(Formerly Kreido Biofuels, Inc.)
September 30,NOTES TO COMBINED FINANCIAL STATEMENTS
FOR THE THREE MONTHS ENDED MARCH 31, 2022 AND 2021 and December 31, 2020
(Currency expressed in United States Dollars (“US$”), except for number of shares)
(Unaudited)
NOTE – 1 -DESCRIPTION OF BUSINESS AND ORGANIZATION AND BUSINESS
Nature of Business
Namliong Skycosmos, Inc. (formerly Kreido Biofuels, Inc.) (the “Company” or “KRBF”) was incorporated as Gemwood Productions, Inc. under the laws of the State of Nevada on February 7, 2005. Gemwood Productions, Inc. changed its name to Kreido Biofuels, Inc. on November 2, 2006. The Company took its current form on January 12, 2007 when Kreido Laboratories (“Kreido Labs”), completed a reverse triangular merger with Kreido Biofuels,On April 19, 2022, we changed the company name to Namliong Skycosmos, Inc.
Kreido Labs, formerly known as Holl Technologies Company, was incorporatedOur current business will be to seek to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. We have not selected any specific business combination target and we have not, nor has anyone on January 13, 1995 under the laws of the State of California. Since incorporation, Kreido Labs has been engaged in activities requiredour behalf, initiated any substantive discussions, directly or indirectly, with any business combination target.
Our acquisition strategy will be to develop, patent and commercialize its products. Kreido Labs was the creator of reactor technology that was designed to enhance the manufacturing ofassess a broad range of chemical products.
The cornerstone of Kreido Labs’ technology was its patented STT® (Spinning Tube in Tube) diffusional chemical reacting system, which were bothpotential business combination targets and complete a licensable process and a licensable system.business combination. In 2005,doing so, we will evaluate the Company demonstrated how the STT® could make biodiesel from vegetable oil rapidly with almost complete conversion and less undesirable by-products. The Company had continued to pursue this activity, built and tested a pilot biodiesel production unit and, prior to June 20, 2008, was in the process of developing the first of its commercial biodiesel production plants in the United States that, if constructed and put into operation, was expected to produce approximately 33 million to 50 million gallons per year. On June 20, 2008, the Company announced that due to the weakeninghistorical financial statements of the economy, the continuedtarget, its management, and projected future results. In evaluating a prospective target business, we expect to conduct a thorough due diligence review that will encompass, among other things, meetings with incumbent management and employees, document reviews, inspection of facilities, as well as a review of financial market turmoil and the inabilityother information that will be made available to raise needed capital to finance site construction and plant start-up costs, the Company was suspending work regarding its flagship biodiesel production plant at the Port of Wilmington, North Carolina. In November of 2017, the Company discontinued operations of its subsidiary, Kreido Labs, Inc.us.
We are currently seeking newnot prohibited from pursuing a business opportunities with established business entities for merger with or acquisition of a target business. In certain instances, a target business may wish to become our subsidiary or may wish to contribute assets to us rather than merge. We have not yet begun negotiations or entered into any definitive agreements for potential new business opportunities, and there can be no assurance that we will be able to enter into any definitive agreements.
Any new acquisition or business opportunities that we may acquire will require additional financing. There can be no assurance, however, that we will be able to acquire the financing necessary to enable us to pursue our plan of operation. If our company requires additional financing and we are unable to acquire such funds, our business may fail.
Management of our company believes that there are benefits to being a reporting companycombination with a classcompany that is affiliated with our management, but we have no plans to do so. We do not plan to retain a significant equity position after closing of securities quoted onany acquisition and management does not plan to continue as part of the OTC Markets, such as: (i) the ability to use registered securities to acquire assets or businesses; (ii) increased visibility in the financial community; (iii) the facilitation of borrowing from financial institutions; (iv) potentially improved trading efficiency; (v) potential stockholder liquidity; (vi) potentially greater ease in raising capital subsequent to an acquisition; (vii) potential compensation of key employees through stock awards or options; (viii) potentially enhanced corporate image; and (ix) a presence in the United States’ capital market.new management team.
We may seek ahave not selected any specific business opportunity with entities that have recently commenced operations, or entities who wish to utilize the public marketplace to raise additional capital in order to expand business development activities, to develop a new product or service, or for other corporate purposes. We may acquire assets and establish wholly-owned subsidiaries in various businesses or acquire existing businesses as subsidiaries.
In implementing a structure for a particular business acquisition or opportunity, we may become a party to a merger, consolidation, reorganization, joint venture, or licensing agreement with another corporation or entity. We may also acquire stock or assets of an existing business. Upon the consummation of a transaction, it is anticipated that ourcombination target. Our sole officer and two directorsdirector presently has, and in the future may have additional, fiduciary or contractual obligations to other entities pursuant to which such officer or director is or will continuebe required to manage the Company however; it is possible that with anypresent a business combination new managementopportunity. Accordingly, if our officer and director becomes aware of a business combination opportunity which is suitable for an entity to which he or she has then-current fiduciary or contractual obligations, he or she will be appointed.
KREIDO BIOFUELS, INC.
Noteshonor his or her fiduciary or contractual obligations to Condensed Financial Statements
September 30, 2021 and December 31, 2020
(Unaudited)present such opportunity to such entity. We do not believe, however, that the fiduciary duties or contractual obligations of our officer/director will materially affect our ability to complete our business combination.
Our executive officer is not required to commit any specified amount of time to our affairs, and, accordingly, will have conflicts of interest in allocating management time among various business activities, including identifying potential business combination targets and monitoring the related due diligence.
On December 14, 2021, certain shareholders owning 13,099,243 of our common stock, representing a majority of issued and outstanding shares, agreed to sell their shares to 6 shareholders. This constitutes a change in control of the Company.
5 |
NOTE – 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
BasisThe accompanying condensed financial statements reflect the application of Presentationcertain significant accounting policies as described in this note and elsewhere in the accompanying financial statements and notes.
The
l | Basis of presentation |
These accompanying condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America.
The accompanying condensed financial statements have been prepared by the Company without audit. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations and cash flows for the nine months ended September 30, 2021 and 2020 have been made.
Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. It is suggested that these financial statements be read in conjunction with the financial statements and notes thereto included in the Company’s December 31, 2020 audited financial statements. The results of operations for the periods ended September 30, 2021 are not necessarily indicative of the operating results for the full year.
Principles of Consolidation
The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary, Kreido Laboratories, Inc. All significant intercompany balances and transactions have been eliminated in consolidation.
Accounting Estimates
The preparation of the financial statementsU.S. Dollars in conformity with generally accepted accounting principles in the United States of America requires(“U.S. GAAP”) for interim financial information pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary to make the financial statements not misleading have been included. Operating results for the interim period ended March 31, 2022 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2022. The information included in this Form 10-Q should be read in conjunction with Management’s Discussion and Analysis, and the financial statements and notes thereto included in the Company’s Form 10-K for the fiscal year ended December 31, 2021, filed with the SEC on March 18, 2022.
l | Use of estimates and assumptions |
In preparing these condensed financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities atin the date of the financial statementsbalance sheet and the reported amounts of revenues and expenses during the reporting period.periods reported. Actual results couldmay differ from thosethese estimates.
Fair Value of Financial Instruments
Financial instruments, including cash and accrued expenses and other liabilities are carried at amounts, which reasonably approximate their fair value due to the short-term nature of these amounts or due to variable rates of interest, which are consistent with market rates.
l | Net loss per share |
Loss per Common Share
Basic loss per share is computedcalculated by dividing the Company’s net loss availableapplicable to common shareholders by the weighted average number of outstanding common shares during the period. Diluted lossearnings per share gives effectis calculated by dividing the Company’s net income available to all dilutive potential common shareholders by the diluted weighted average number of shares outstanding during the period. Dilutive loss per share excludes all potential common shares if their effect is anti-dilutive. For the nine months ended September 30, 2021 and 2020 there were no potentially dilutive debt or equity instruments issued or outstanding.
l | Income taxes |
Cash and Cash Equivalents
The Company considers all highly liquid investment with an original maturity of three months or less to be cash equivalents.
Stock-based compensation
The Company recognizes compensation expense for all stock-based compensation awards based onadopted the grant-date fair value estimated in accordance with theASC 740 Income tax provisions of ASC 718.
Income Taxes
Under ASC 740, ”Income Taxes,” deferredparagraph 740-10-25-13, which addresses the determination of whether tax assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences arebenefits claimed or expected to be recovered or settled. Valuation allowances are established whenclaimed on a tax return should be recorded in the condensed financial statements. Under paragraph 740-10-25-13, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that some or allthe tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the condensed financial statements from such a position should be measured based on the largest benefit that has a greater than fifty percent (50%) likelihood of being realized upon ultimate settlement. Paragraph 740-10-25-13 also provides guidance on de-recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures. The Company had no material adjustments to its liabilities for unrecognized income tax benefits according to the provisions of paragraph 740-10-25-13.
The estimated future tax effects of temporary differences between the tax basis of assets and liabilities are reported in the accompanying balance sheets, as well as tax credit carry-backs and carry-forwards. The Company periodically reviews the recoverability of deferred tax assets willrecorded on its balance sheets and provides valuation allowances as management deems necessary.
l | Uncertain tax positions |
The Company did not be realized. As of September 30, 2021take any uncertain tax positions and December 31, 2020 there werehad no deferred taxes dueadjustments to its income tax liabilities or benefits pursuant to the uncertaintyASC 740 provisions of Section 740-10-25 for the realization of net operating loss or carry forward prior to expiration.periods ended March 31, 2022 and 2021.
6 |
l | Related parties | |
KREIDO BIOFUELS, INC.
Notes to Condensed Financial Statements
September 30, 2021 and December 31, 2020
(Unaudited)
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
Fair Value of Financial Instruments
The Company follows guidancethe ASC 850-10, Related Party for accountingthe identification of related parties and disclosure of related party transactions.
Pursuant to section 850-10-20 the related parties include a) affiliates of the Company; b) entities for fair value measurements of nonfinancial items that are recognized or disclosed at fair valuewhich investments in their equity securities would be required, absent the financial statements on a recurring basis. Additionally, the Company adopted guidance for fair value measurement related to nonfinancial items that are recognized and disclosed at fair value in the financial statements on a nonrecurring basis. The guidance establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to measurements involving significant unobservable inputs (Level 3 measurements). The three levelselection of the fair value hierarchyoption under the Fair Value Option Subsection of section 825–10–15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and Income-sharing trusts that are as follows:managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.
Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date.
Level 2 inputs are inputsThe condensed financial statements shall include disclosures of material related party transactions, other than quoted prices included within Level 1thatcompensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are observable for the asset or liability, either directly or indirectly.
Level 3 inputs are unobservable inputs for the asset or liability. The carrying amounts of financial assets such as cash approximate their fair values because of the short maturity of these instruments.
Recent Accounting Pronouncements
The FASB established the Accounting Standards Codification (“Codification” or ”ASC”) as the source of authoritative accounting principles recognized by the FASB to be applied by nongovernmental entitieseliminated in the preparation of consolidated or combined financial statements is not required in accordance with generally accepted accounting principlesthose statements. The disclosures shall include: a) the nature of the relationship(s) involved; b) a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c) the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the United States (“GAAP”).method of establishing the terms from that used in the preceding period; and d) amount due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.
l | Commitments and contingencies |
The Company follows the ASC 450-20, Commitments to report accounting for contingencies. Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or un-asserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or un-asserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.
RulesIf the assessment of a contingency indicates that it is probable that a material loss has been incurred and interpretative releasesthe amount of the Securitiesliability can be estimated, then the estimated liability would be accrued in the Company’s condensed financial statements. If the assessment indicates that a potentially material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and Exchange Commission (“SEC”) issued under authorityan estimate of federal securities laws are also sourcesthe range of GAAP for SEC registrants.possible losses, if determinable and material, would be disclosed.
OtherLoss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed. Management does not believe, based upon information available at this time that these matters will have a material adverse effect on the Company’s financial position, results of operations or cash flows. However, there is no assurance that such matters will not materially and adversely affect the Company’s business, financial position, and results of operations or cash flows.
l | Recent accounting pronouncements |
From time to time, new accounting pronouncements are issued by the Financial Accounting Standard Board (“FASB”) or other standard setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes that the impact of recently issued standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected toyet effective will not have a material impact on its financial position or results of operations upon adoption.
7 |
In September 2016, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2016-13, “Financial Instruments – Credit Losses (Topic 326)” (“ASU 2016-13”), which requires the immediate recognition of management’s estimates of current and expected credit losses. In November 2018, the FASB issued ASU 2018-19, which makes certain improvements to Topic 326. In April and May 2019, the FASB issued ASUs 2019-04 and 2019-05, respectively, which adds codification improvements and transition relief for Topic 326. In November 2019, the FASB issued ASU 2019-10, which delays the effective date of Topic 326 for Smaller Reporting Companies to interim and annual periods beginning after December 15, 2022, with early adoption permitted. In November 2019, the FASB issued ASU 2019-11, which makes improvements to certain areas of Topic 326. In February 2020, the FASB issued ASU 2020-02, which adds an SEC paragraph, pursuant to the issuance of SEC Staff Accounting Bulletin No. 119, to Topic 326. Topic 326 is effective for the Company for fiscal years and interim reporting periods within those years beginning after December 15, 2022. Early adoption is permitted for interim and annual periods beginning December 15, 2019. The Company is currently evaluating the potential impact of adopting this guidance on the financial statements upon adoption. statements.
On January 1, 2020, the Company adopted ASU No. 2017-04, “Intangibles and Other (Topic 350): Simplifying the Test for Goodwill Impairment”, which eliminates the requirement to calculate the implied fair value of goodwill, but rather requires an entity to record an impairment charge based on the excess of a reporting unit’s carrying value over its fair value. Adoption of this ASU did not have a material effect on the condensed financial statements.
The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and does not discuss recentbelieve the future adoption of any such pronouncements that are not anticipatedmay be expected to have ancause a material impact on or are unrelated to its financial condition or the results of operations, cash flows or disclosures.its operations.
NOTE – 3 - GOING CONCERN UNCERTAINTIES
The accompanying condensed financial statements have been prepared using the going concern basis of accounting, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.
In order to continue as a going concern, the Company will need, among other things, additional capital resources. Management’sManagement's plan is to obtain such resources for the Company by obtaining capital from management sufficient to meet its minimal operating expenses and seeking equity and/or debt financing. However, Management cannot provide any assurances that the Company will be successful in accomplishing any of its plans, which raises substantial doubt about the ability of the Company to continue as a going concern.
The ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plans described in the preceding paragraph and eventually secure other sources of financing and attain profitable operations. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.
KREIDO BIOFUELS, INC.
Notes to Condensed Financial Statements
September 30, 2021 and December 31, 2020
(Unaudited)
NOTE – 4 – STOCKHOLDERS’ EQUITYAMOUNT DUE TO A RELATED PARTY
The amount represented temporary advances from the Company’s director for working capital purpose, which were unsecured, interest-free and had no fixed terms of repayments.
NOTE – 5 STOCKHOLDERS’ DEFICIT
Preferred stock
The Company’s authorized shares were
shares of preferred stock, with a par value of $ .Common Stock
The Company’s Articles of Incorporation authorize the issuance of up to shares,stock, par value $0.001$ per share, and preferred shares, also $.001$ par value.
There were 1,956,513 and shares of common stock outstanding at September 30, 2021March 31, 2022 and December 31, 2020. 2021, respectively.
There were no preferred shares issued and outstanding during any periods presented.
8 |
NOTE – 6 INCOME TAX
On October 15,December 22, 2017, the 2019 Tax Cuts and Jobs Act (the “Tax Act”) was enacted into law including a one-time mandatory transition tax on accumulated foreign earnings and a reduction of the corporate income tax rate to 21% effective January 1, 2018, among others. We are required to recognize the effect of the tax law changes in the period of enactment, such as determining the transition tax, remeasuring our U.S. deferred tax assets and liabilities as well as reassessing the net realizability of our deferred tax assets and liabilities. The Company does not have any foreign earnings and therefore, we do not anticipate the impact of a transition tax.
The cumulative tax effect at the expected rate of 21% as of March 31, 2022 and December 31, 2021 of significant items comprising our net deferred tax amount is as follows:
March 31, 2022 | December 31, 2021 | |||||||
Net operating loss carryover | $ | 49,485,838 | $ | 49,451,088 | ||||
Deferred tax asset | 10,392,026 | 10,384,728 | ||||||
Impact of rate changes | ||||||||
Less: valuation allowance | (10,392,026 | ) | (10,384,728 | ) | ||||
Net deferred tax asset | $ | 0 | $ | 0 |
At March 31, 2022, the Company had net operating loss carry forwards of approximately $49,485,838 that may be offset against future taxable income. The Tax Act also changed the rules on net operating loss carry forwards. The 20-year limitation was eliminated, giving the taxpayer the ability to carry forward losses indefinitely. However, NOL carry forward arising after January 1, 2020, will now be limited to 80 percent of taxable income.
No tax benefit has been reported in the period ended March 31, 2022, the Company’s financial statements since the potential tax benefit is offset by a valuation allowance of the same amount. Due to the change in ownership provisions of the Tax Reform Act of 1986, net operating loss carry forwards for federal income tax reporting purposes are subject to annual limitations. A change in ownership may limit net operating loss carry forwards in future years. The benefits of our deferred tax assets, including our NOLs, built-in losses and tax credits would be reduced or potentially eliminated if we experienced an “ownership change” under Section 382.
Based on our analysis performed as of March 31, 2022, the Company has experienced an ownership change as defined by Section 382, and, therefore, the NOLs, built-in losses and tax credits we have generated should be subject to a Section 382 limitation as of this reporting date.
NOTE – 7 RELATED PARTY TRANSACTIONS
During the three months ended March 31, 2022 and 2021, the Company has been provided with free office space by its shareholders. The management determined that such cost is nominal and did not recognize the rent expense in its financial statements.
Apart from the transactions and balances detailed elsewhere in these accompanying financial statements, the Company has no other significant or material related party transactions during the periods presented.
NOTE – 8 COMMITMENTS AND CONTINGENCIES
As of March 31, 2022, the Company has no material commitments or contingencies.
NOTE – 9 SUBSEQUENT EVENTS
In accordance with ASC Topic 855, “Subsequent Events”, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before condensed financial statements are issued, 750,000 sharesthe Company has evaluated all events or transactions that occurred after March 31, 2022, up through the date the Company issued the unaudited condensed financial statements.
9 |
Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations.
Namliong SkyCosmos, Inc. (“we” or the “Company”) was incorporated on February 7, 2005 under the name Gemwood Productions. On November 2, 2006, we changed our name to Kreido Biofuels, Inc. On April 19, 2022, the Company changed its common stockname to Namliong SkyCosmos, Inc.
Our registration statement on Form SB-2, file number 333-140718, became effective on June 28, 2007. Subsequent to the filing of our Annual Report on Form 10-K for the year ended December 31, 2008, we continued to file annual and quarterly reports with the Securities and Exchange Commission on a third party for services rendered, at the current market value of $0.55per share, totaling $412,500 as stock-based compensation recorded duringvoluntary basis through the quarter ended September 30, 2021. At September 30, 2021, there were 750,0002009. On February 16, 2009, we elected to terminate our registration and our election to file periodic reports. On March 2, 2018, we filed a registration statement on Form 10, and the registration statement became effective on May 8, 2018.
On November 10, 207, the Company issued 142,924,167 shares of its common stock to be issued.Reed Petersen, its then officer and director in consideration of cash of $21,434 paid by him to satisfy accounts payable of the Company, and in conversion of $150,075 in accounts payable which he had acquired from the owners of that debt. This transaction was exempt under section 4(2) of the Securities Act of 1933 as one not involving any public solicitation or public offering, and was also exempt under Section 4(5) as an offering solely to accredited investors not involving any public solicitation or public offering.
2019On June 5, 2018, the Company and its sole officer and director, G. Reed Petersen, entered into that certain Stock Purchase Agreement (the “Stock Purchase Agreement”), pursuant to which Mr. Petersen agreed to sell to certain purchasers an aggregate of 142,924,167 shares of common stock of the Company (the “Control Shares”), representing approximately 73% of the issued and outstanding stock of the Company, for aggregate cash consideration of $420,000 in accordance with the terms and conditions of the Stock Purchase Agreement. The sale of the Control Shares consummated on June 29, 2018. In connection with the sale of the Control Shares, G. Reed Petersen resigned from his positions as the sole executive officer and director of the Company, effective June 29, 2018. Mr. Petersen’s departure was not due to any dispute or disagreement with the Company on any matter related to the Company’s operations, policies or practices. Concurrently, the Board of Directors appointed Wai Lim Wong to fill the vacancies created by Mr. Petersen’s resignation, and to serve as the Company’s sole Director, Chief Executive Officer, Chief Financial Officer and Secretary.
During 2019,
On September 7, 2021, Board of Directors Board of Directors accepted the resignation of Wai Lim Wong, and appointed CHAN Kwok Wai Davy as a related party forgave annew member of the Board of Directors and CEO.
On December 14, 2021, the Company, nine stockholders (the “Selling Stockholders”) and six purchasers (the “Purchasers”) entered into a Stock Purchase Agreement (the “SPA”), pursuant to which the Purchasers agreed to purchase from the Selling Stockholders 13,099,243 shares of common stock of the Company, par value $0.001 (collectively, the “Shares”), constituting approximately 89% of the issued and outstanding balanceshares of $21,350common stock of the Company, for aggregate consideration of Four Hundred Twenty Thousand Dollars ($420,000) in accordance with the terms and conditions of the SPA. The acquisition of the Shares consummated on December 20, 2021, and the forgiveness of related party debt was recorded in additional paid-in capital.Shares were ultimately purchased by the following individuals:
Selling Shareholder | No. of Common Stock | Purchaser |
DOU Chu Ju | 554,856 | PG MAX & CO, LLC |
ZHANG Chao | 214,387 | CHEN,HSUEH-NI |
HEUNG Kin Leung Kenny | 55,000 | HSIAO, CHUNG-PIN |
HEUNG Pak Kuen | 55,000 | HSIAO, CHUNG-PIN |
HEUNG Teui Yee | 55,000 | HSIAO, YU-CHIAO |
KWAN Chin Man | 55,000 | HSIAO, YU-CHIAO |
LEUNG Wong Hung | 55,000 | HSU, CHENG-HSING |
MAK Chit Ming Brian | 55,000 | HSU, CHENG-HSING |
Pang King Sau Nelson | 12,000,000 | Orient Express & Co., Ltd. |
Total | 13,099,243 |
NOTE 5 – RELATED PARTY TRANSACTIONS
As of September 30, 2021 and December 31, 2020, the Company had
10 |
Orient Express & Co., Ltd. holds a related party payable in the amount of $34,596 and $33,621. The related party payable is a shareholdercontrolling interest in the Company, who advanced a totaland may unilaterally determine the election of $975 during the nine months ended September 30, 2021 to provide working capital forBoard and other substantive matters requiring approval of the Company. The advances are unsecured, non-interestCompany’s stockholders. Cheng Hsing Hsu, our new Chief Financial Officer and due on demand.
NOTE 6 – SUBSEQUENT EVENTSDirector, is the director and controlling shareholder of Orient Express & Co., Ltd.
The Company evaluated subsequent events from September 30, 2021, through the date the financial statements were issued. There have been no subsequent events after September 30, 2021 for which disclosure is required.
On October 15, 2021, the Company issued 750,000 shares of its common stock to a third party for services rendered.
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Future Operating Plan
We are currently seeking new business opportunities with established business entities for merger with or acquisition of a target business. In certain instances, a target business may wish to become our subsidiary or may wish to contribute assets to us rather than merge. We have not yet begun negotiations or entered into any definitive agreements for potential new business opportunities, and there can be no assurance that we will be able to enter into any definitive agreements.
Any new acquisition or business opportunities that we may acquire will require additional financing. There can be no assurance, however, that we will be able to acquire the financing necessary to enable us to pursue our plan of operation. If our company requires additional financing and we are unable to acquire such funds, our business may fail.
Management of our company believes that there are benefits to being a reporting company with a class of securities quoted on the OTC Markets, such as: (i) the ability to use registered securities to acquire assets or businesses; (ii) increased visibility in the financial community; (iii) the facilitation of borrowing from financial institutions; (iv) potentially improved trading efficiency; (v) potential stockholder liquidity; (vi) potentially greater ease in raising capital subsequent to an acquisition; (vii) potential compensation of key employees through stock awards or options; (viii) potentially enhanced corporate image; and (ix) a presence in the United States’ capital market.
We may seek a business opportunity with entities that have recently commenced operations, or entities who wish to utilize the public marketplace to raise additional capital in order to expand business development activities, to develop a new product or service, or for other corporate purposes. We may acquire assets and establish wholly-owned subsidiaries in various businesses or acquire existing businesses as subsidiaries.
In implementing a structure for a particular business acquisition or opportunity, we may become a party to a merger, consolidation, reorganization, joint venture, or licensing agreement with another corporation or entity. We may also acquire stock or assets of an existing business. Upon the consummation of a transaction, it is anticipated thatthe sale, Chan Kwok Wai Davy, our sole executive officer and twodirector, resigned from all of his positions with the Company, effective December 20, 2021. His resignation was not due to any dispute or disagreement with the Company on any matter relating to the Company’s operations, policies or practices.
Concurrently with such resignation, the following individuals were appointed to serve in the positions set forth next to their names, until the next annual meeting of stockholders of the Company and until such director’s successor is elected and qualified or until such director’s earlier death, resignation or removal:
Name | Position |
HSIAO, Chung Pin | Chief Executive Officer and Director |
HSIAO, Yu-Chiao | Secretary and Director |
HSU, Cheng Hsing | Chief Financial Officer and Director |
Chung Pin HSIAO and Yu Chiao HSIAO are siblings. Except as set forth in the foregoing, none of the directors or executive officers has a direct family relationship with any of the Company’s directors or executive officers, or any person nominated or chosen by the Company to become a director or executive officer. All officers and directors will continueserve in his or her positions without compensation. The Company hopes to manageenter into a compensatory arrangement with each officer in the Company however; itfuture.
Our current business is possible that with anyto seek to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination newwith one or more businesses. Our acquisition strategy is to assess a broad range of potential business combination targets and complete a business combination. In doing so, we will evaluate the historical financial statements of the target, its management, and projected future results. In evaluating a prospective target business, we expect to conduct a thorough due diligence review that will encompass, among other things, meetings with incumbent management and employees, document reviews, inspection of facilities, as well as a review of financial and other information that will be appointed.made available to us.
Results of Operations
Following is management’s discussion of the relevant items affecting results of operations for the three months ended March 31, 2022 and nine month periods ended September 30, 2021 and 2020.2021.
Revenues. Revenues, net.The Company has not generated net revenues of $-0- during the three and nine months ended September 30, 2021 as compared to $-0- for the threeMarch 31, 2022 and nine months ended September 30, 2020.2021.
General and Administrative Expenses.For the three months ended September 30, 2021,March 31, 2022, the Company had general and administrative expenses in the amount of $414,133,$34,750, as compared to $2,764$2,300 for the same period ended September 30, 2020. General and administrative expenses for the nine months ended September 30, 2021 were $416,170 compared to $4,435 during the nine months ended September 30, 2020. These increases areMarch 31, 2021. The increase was mainly due to stock-based compensation expense, transfers agents fees, Securitythe addition of legal fee, accounting and Exchange Commission fees, and State Registrations feesaudit fee incurred by the Company.
Professional Fees. For the three months ended September 30, 2021, the Company had Professional Fees in the amount of $11,273, compared to $2,500 for the same period ended September 30, 2020. Professional Fee expenses for the nine months ended September 30, 2021 were $11,273 compared to $2,500 during the nine months ended September 30, 2020. These increases are due to auditor, accounting and legal fees incurred by the Company.
Other Income (Expense). The Company had net other expenses of $-0- for the three and nine months ended September 30, 2021 compared to $-0- during the three and nine months ended September 30, 2020.
Net Loss. For the three months ended September 30, 2021,March 31, 2022, the Company hadincurred a net loss of $425,406,$34,750, as compared to $5,264a net loss of $2,300 for the same period ended September 30, 2020. The Company had a net loss of $427,443 for the nine months ended September 30, 2021 compared to a $6,935 net loss during the nine months ended Septemner 30, 2020.March 31, 2021. The increase in net loss was due to the increase in professional fees and general and administrative fees incurred by the Company.
Liquidity and Capital Resources
As of September 30, 2021,March 31, 2022, our primary source of liquidity consisted of $37,693$-0- in cash and cash equivalents. We hold most of our cash reserves in local checking accounts with local financial institutions. Since inception, we have financed our operations through a combination of short and long-term loans, and through the private placement of our common stock.
11 |
We have sustained significant net losses which have resulted in a total stockholders’ deficit at September 30, 2021as of $84,381March 31, 2022 of $35,505 and are currently experiencing a substantial shortfall in operating capital which raises doubt about our ability to continue as a going concern. We anticipate a net loss for the yearthree months ended DecemberMarch 31, 20212022 and with the expected cash requirements for the coming months, without additional cash inflows from an increase in revenues combined with continued cost-cutting or a receipt of cash from capital investment, there is substantial doubt as to the Company’s ability to continue operations.
There is presently no agreement in place with any source of financing for the Company and we cannot assure you that the Company will be able to raise any additional funds, or that such funds will be available on acceptable terms. Funds raised through future equity financing will likely be substantially dilutive to current shareholders. Lack of additional funds will materially affect the Company and its business and may cause us to cease operations. Consequently, shareholders could incur a loss of their entire investment in the Company.
Off-Balance Sheet Arrangements
We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.
Contractual Obligations
As a “smaller reporting company” as defined by Item 10 of Regulation S-K, the Company is not required to provide this information.
Critical accounting policies
l | Use of estimates and assumptions |
The preparation of our
In preparing these condensed financial statements, requires management to makemakes estimates and assumptions that affect the reported amounts of assets and liabilities andin the disclosure of contingent assetsbalance sheet and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. On an on-going basis, management evaluates its estimates and judgments which are based on historical experience and on various other factors that are believed to be reasonable under the circumstances. The results of their evaluation form the basis for making judgments about the carrying values of assets and liabilities.periods reported. Actual results may differ from these estimates under different assumptions and circumstances. Our significant accounting policies areestimates.
l | Net loss per share |
Basic loss per share is calculated by dividing the Company’s net loss applicable to common shareholders by the weighted average number of common shares during the period. Diluted earnings per share is calculated by dividing the Company’s net income available to common shareholders by the diluted weighted average number of shares outstanding during the period.
l | Income taxes |
The Company adopted the ASC 740 Income tax provisions of paragraph 740-10-25-13, which addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the condensed financial statements. Under paragraph 740-10-25-13, the Company may recognize the tax benefit from an uncertain tax position only if it is more fully discussedlikely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in Note 2 to ourthe condensed financial statements contained herein.from such a position should be measured based on the largest benefit that has a greater than fifty percent (50%) likelihood of being realized upon ultimate settlement. Paragraph 740-10-25-13 also provides guidance on de-recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures. The Company had no material adjustments to its liabilities for unrecognized income tax benefits according to the provisions of paragraph 740-10-25-13.
Recent accounting pronouncementsThe estimated future tax effects of temporary differences between the tax basis of assets and liabilities are reported in the accompanying balance sheets, as well as tax credit carry-backs and carry-forwards. The Company periodically reviews the recoverability of deferred tax assets recorded on its balance sheets and provides valuation allowances as management deems necessary.
12 |
l | Uncertain tax positions |
The recentCompany did not take any uncertain tax positions and had no adjustments to its income tax liabilities or benefits pursuant to the ASC 740 provisions of Section 740-10-25 for the periods ended March 31, 2022 and 2021.
l | Related parties |
The Company follows the ASC 850-10, Related Party for the identification of related parties and disclosure of related party transactions.
Pursuant to section 850-10-20 the related parties include a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of section 825–10–15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and Income-sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.
The condensed financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include: a) the nature of the relationship(s) involved; b) a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c) the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d) amount due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.
l | Commitments and contingencies |
The Company follows the ASC 450-20, Commitments to report accounting for contingencies. Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or un-asserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or un-asserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.
If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s condensed financial statements. If the assessment indicates that a potentially material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed.
Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed. Management does not believe, based upon information available at this time that these matters will have a material adverse effect on the Company’s financial position, results of operations or cash flows. However, there is no assurance that such matters will not materially and adversely affect the Company’s business, financial position, and results of operations or cash flows.
13 |
l | Recent accounting pronouncements |
From time to time, new accounting pronouncements are issued by the Financial Accounting Standard Board (“FASB”) or other standard setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes that the impact of recently issued standards that have been issued or proposed by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected toyet effective will not have a material impact on our unaudited condensed consolidatedits financial statementsposition or results of operations upon adoption.
ITEMIn September 2016, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2016-13, “Financial Instruments – Credit Losses (Topic 326)” (“ASU 2016-13”), which requires the immediate recognition of management’s estimates of current and expected credit losses. In November 2018, the FASB issued ASU 2018-19, which makes certain improvements to Topic 326. In April and May 2019, the FASB issued ASUs 2019-04 and 2019-05, respectively, which adds codification improvements and transition relief for Topic 326. In November 2019, the FASB issued ASU 2019-10, which delays the effective date of Topic 326 for Smaller Reporting Companies to interim and annual periods beginning after December 15, 2022, with early adoption permitted. In November 2019, the FASB issued ASU 2019-11, which makes improvements to certain areas of Topic 326. In February 2020, the FASB issued ASU 2020-02, which adds an SEC paragraph, pursuant to the issuance of SEC Staff Accounting Bulletin No. 119, to Topic 326. Topic 326 is effective for the Company for fiscal years and interim reporting periods within those years beginning after December 15, 2022. Early adoption is permitted for interim and annual periods beginning December 15, 2019. The Company is currently evaluating the potential impact of adopting this guidance on the financial statements.
On January 1, 2020, the Company adopted ASU No. 2017-04, “Intangibles and Other (Topic 350): Simplifying the Test for Goodwill Impairment”, which eliminates the requirement to calculate the implied fair value of goodwill, but rather requires an entity to record an impairment charge based on the excess of a reporting unit’s carrying value over its fair value. Adoption of this ASU did not have a material effect on the condensed financial statements.
The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and does not believe the future adoption of any such pronouncements may be expected to cause a material impact on its financial condition or the results of its operations.
Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISKQuantitative and Qualitative Disclosures About Market Risk
As a smaller“smaller reporting company,company”, we are not required to provide the information required by this information.
ITEM 4. CONTROLS AND PROCEDURESItem.
Management’s Item 4. Controls and Procedures
Evaluation onof Disclosure Controls and ProceduresProcedures.
We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports filed under the Securities Exchange Act of 1934,, as amended, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’sCommission's rules and forms, and that such information is accumulated and communicated to our management, to allow for timely decisions regarding required disclosure.
As of September 30, 2021,March 31, 2022, the end of our thirdfiscal quarter, we carried out an evaluation, under the supervision of our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based on the foregoing, we concluded that our disclosure controls and procedures were not effective as of the end of the period covered by this quarterly report. Our board of directors has only one member. We do not have a formal audit committee.
Changes in Internal Control over Financial ReportingControls
There have been no significant changes in our internal controls over financial reporting identified in connection with the evaluation required by paragraph (d) of Securities Exchange Act Rule 13a-15 or Rule 15d-15 that occurred duringin the quarter ended September 30, 2021March 31, 2022 that have materially affected, or are reasonably likely to materially affect, our internal controlscontrol over financial reporting.
14 | |
PART II
- OTHER INFORMATION
ITEMItem 1. LEGAL PROCEEDINGSLegal Proceedings
From time to time, we are a partymay become involved in litigation relating to certain legal proceedings incidental toclaims arising out of its operations in the normal course of our business includingbusiness. We are not involved in any pending legal proceeding or litigation and, to the enforcementbest of our rights under contracts with purchasers and suppliers. While the outcomeknowledge, no governmental authority is contemplating any proceeding to which we area party or to which any of these legal proceedings cannot at this timeour properties is subject, which would reasonably be predicted with certainty, we do not expect that these proceedings willlikely to have a material adverse effect upon our financial condition or results of operations.on us.
ITEMItem 1A. RISK FACTORSRisk Factors
As a smaller“smaller reporting company,company”, we are not required to provide the information required by this item.Item.
ITEMItem 2. UNREGISTERED SALES OF EQUITY SECURITIESAND USE OF PROCEEDS
NoneUnregistered Sales of Equity Securities and Use of Proceeds
ITEMNone.
Item 3. DEFAULTS UPON SENIOR SECURITIESDefaults Upon Senior Securities
NoneNone.
ITEMItem 4. MINE SAFETY DISCLOSURESMine Safety Disclosures
Not applicable.Applicable.
ITEMItem 5. OTHER INFORMATIONOther Information
Not applicable.None.
15 |
Item 6. Exhibits
Exhibit No. | Description | |
Articles of Incorporation(1) | ||
3.2 | Certificate of Amendment* | |
ITEM 6. EXHIBITS
The following documents are filed as exhibits to this Form 10-Q:
INDEX TO EXHIBITS
Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document) (3) | ||
101.SCH | Inline XBRL Taxonomy Extension Schema Document (3) | |
Inline XBRL Taxonomy Extension Calculation Linkbase Document (3) | ||
101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document (3) | |
101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document (3) | |
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document (3) | |
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) (3) |
_________________
* | Filed herewith. | |
(1) | Incorporated by reference to the Exhibits to the Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 18, 2022. | |
(2) | Incorporated by reference to Exhibit 3.3 to the Annual Report on Form 10-KSB filed with the Securities and Exchange Commission on April 4, 2007 (File No. 333-130606). | |
(3) | XBRL Information is furnished and not filed or a part of |
16 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|